More about

Lymphoma

News
June 16, 2023
3 min watch
Save

VIDEO: Therapeutic options for hard-to-treat lymphoma

VIDEO: Therapeutic options for hard-to-treat lymphoma

In this video, Jing-Zhou Hou, MD, PhD, medical oncologist and hematologist, clinical instructor and co-chair of the hematological malignancies program at UPMC Hillman Cancer Center, discussed therapeutic options for hard to treat lymphoma.

News
June 16, 2023
5 min watch
Save

VIDEO: New advancements, molecular targets in lymphoma

VIDEO: New advancements, molecular targets in lymphoma

In this video, Jing-Zhou Hou, MD, PhD, medical oncologist and hematologist, clinical instructor and co-chair of the hematological malignancies program at UPMC Hillman Cancer Center, discussed advancements in molecular targets in lymphoma.

News
June 16, 2023
1 min read
Save

FDA approves Columvi for advanced diffuse large B-cell lymphoma

FDA approves Columvi for advanced diffuse large B-cell lymphoma

The FDA granted accelerated approval to glofitamab-gxbm for treatment of certain adults with relapsed or refractory diffuse large B-cell lymphoma.

News
June 14, 2023
1 min watch
Save

VIDEO: 'Significant progress' in mantle cell lymphoma leads to recent approvals

VIDEO: 'Significant progress' in mantle cell lymphoma leads to recent approvals

In this video, Matthew Matasar, MD, chief of the division of blood disorders at Rutgers Cancer Institute, discusses mantle cell lymphoma research presented at ASCO Annual Meeting.

News
June 06, 2023
2 min read
Save

Radiotherapy after chemoimmunotherapy may be omittable for certain patients with lymphoma

Radiotherapy after chemoimmunotherapy may be omittable for certain patients with lymphoma

CHICAGO — Radiation therapy can be safely omitted for patients with primary mediastinal B-cell lymphoma who demonstrate a complete metabolic response after chemoimmunotherapy, according to data presented at ASCO Annual Meeting.

News
June 05, 2023
3 min read
Save

Split-dose R-CHOP regimen effective for older adults with newly diagnosed lymphoma

Split-dose R-CHOP regimen effective for older adults with newly diagnosed lymphoma

CHICAGO — A split-dose approach to the standard R-CHOP chemotherapy regimen resulted in a 71% complete response rate among older adults with newly diagnosed diffuse large B-cell lymphoma, results from a phase 2 study showed.

News
June 05, 2023
3 min read
Save

CAR-T ‘definitively’ superior as second-line therapy for large B-cell lymphoma

CAR-T ‘definitively’ superior as second-line therapy for large B-cell lymphoma

CHICAGO — Second-line therapy with axicabtagene ciloleucel conferred a significant increase in OS compared with the current standard of care among adults with relapsed or refractory large B-cell lymphoma, results of the randomized phase 3 ZUMA-7 study showed.

News
May 26, 2023
3 min watch
Save

VIDEO: Recent advances, FDA approvals have ‘changed the landscape rapidly’ in DLBCL

VIDEO: Recent advances, FDA approvals have ‘changed the landscape rapidly’ in DLBCL

In this video interview, Brian Hill, MD, PhD, Director of the Lymphoid Malignancies Program at the Cleveland Clinic Taussig Cancer Institute discusses recent FDA approvals in Lymphoma treatment and care.

News
May 26, 2023
1 min watch
Save

VIDEO: Health disparities in DLBCL care

VIDEO: Health disparities in DLBCL care

In this video interview, Brian Hill, MD, PhD, Director of the Lymphoid Malignancies Program at the Cleveland Clinic Taussig Cancer Institute discusses factors that may keep patients from necessary DLBCL care.

News
May 26, 2023
2 min watch
Save

VIDEO: Greatest areas of unmet need in relapsed, refractory DLBCL

VIDEO: Greatest areas of unmet need in relapsed, refractory DLBCL

In this video interview, Brian Hill, MD, PhD, Director of the Lymphoid Malignancies Program at the Cleveland Clinic Taussig Cancer Institute emphasizes need for consistent type of care of DLBCL patients who do not go into remission.

View more